semaglutide for arthritis Weight Loss: May Help Treat Osteoarthritis, Study Finds Semaglutide May Reverse Damage Caused

Understanding these differences helps you choose the right medication for weight management and metabolic health

Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH

Contact us for a strong advocate on your side.

A new analysis indicates that using GLP-1 drugs for diabetes or obesity early in pregnancy may not pose significant risks to fetus development, providing reassurance for women who inadvertently used these medications prior to realizing they were pregnant.

These findings underscore the potential for GLP-1 RAs to offer tailored protection against complex diabetic complications, marking an advancement in personalized medicine for managing diabetes-acute kidney disease.

Compare five vendors on COAs, testing, batch traceability, and transparency